Show simple item record

dc.contributor.authorMartí Carvajal, Arturo
dc.contributor.authorDe Sanctis, Juan Bautista
dc.contributor.authorDayer, Mark
dc.contributor.authorMartí Amarista, Cristina Elena
dc.contributor.authorAlegría Barrero, Eduardo 
dc.contributor.authorMonge Martín, Diana 
dc.contributor.authorAbd El Aziz, Mohamed
dc.contributor.authorCorrea Pérez, Andrea
dc.contributor.authorNicola, Susana
dc.contributor.authorParise Vasco, Juan Marcos
dc.date.accessioned2022-03-31T09:41:52Z
dc.date.available2022-03-31T09:41:52Z
dc.date.issued2021
dc.identifier.issn1469-493Xspa
dc.identifier.urihttp://hdl.handle.net/10641/2920
dc.description.abstractObjectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the clinical benefits and harms of interleukin‐receptor antagonists and tumor necrosis factor (TNF) inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases. To determine whether interleukin‐receptor antagonists or TNF inhibitors, provided to people both with and without pre‐existing cardiovascular disease, are: useful in preventing adverse cardiovascular outcomes; and safe.spa
dc.language.isoengspa
dc.publisherCochrane Database of Systematic Reviewsspa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.titleInterleukin‐receptor antagonist and tumor necrosis factor inhibitors for theprimary and secondary prevention of atherosclerotic cardiovascular diseases.spa
dc.typearticlespa
dc.description.versionpost-printspa
dc.rights.accessRightsopenAccessspa
dc.description.extent2743 KBspa
dc.identifier.doi10.1002/14651858.CD014741spa
dc.relation.publisherversionhttps://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014741/fullspa


Files in this item

FilesSizeFormatView
Interleukin‐receptor antagonist ...2.678MbPDFView/Open

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 España
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 España